|premium|

Palantir Technologies Stock News and Forecast: PLTR ready for breakout

  • Palantir shares look to break sharply higher.
  • PLTR has been rallying from a low base.
  • The company has been continually signing new contracts.

Palantir Technologies was one of the darlings of the first retail revolution back in January when the Reddit community pushed the PLTR stock price from $26 to $45 in a matter of days. Since then the stock has languished and slid back to a low of $17.06 in May. From here things have started to pick up nicely and quietly for the software firm. Earnings on May 11 were solid if unspectacular with EPS in line, while revenue was $10 million ahead of analyst estimates.

Palantir also announced a few days later that it had a new contract worth $32.5 million with the US Space Force and Air Force. The US CDC (Centre for Disease Control) has also recently announced a renewal of its partnership with Palantir. The earnings release had seen the shares take a brief spike lower to bottom out at $17.06 as mentioned, but since then it has been all one-way bull traffic. 

Should I buy PLTR now?

Wait for confirmation. That is the quick answer in this author's opinion. Some key levels are approaching, and some interesting potential makes a PLTR forecast dependant on a few key levels. First, PLTR has run into huge resistance at $24.70. This is the point of control since Palantir's IPO. The point of control is the price at which there has been the highest volume over the period in question. In this case, since IPO, it is the fairest price or the price that buyers and sellers transacted at the most. In effect, it is an equilibrium, so it will be a strong resistance to break. However, buying a break of this level is where things could get interesting.

The volume profile on the left of the chart shows the lack of volume above this key $24.70 level. The volume totally thins out above $25.40, and this could be a good entry point for a breakout as it will confirm the break of $24.70 and the 100-day moving average. Once above $30, there is a vacuum of volume that could accelerate any price moves. The issue is a pullback is quite likely on the first test of any resistance. Before $24.70 goes, PLTR shares could retrace toward the 21-day and 50-day moving average convergence as a support at $22.90. $20.97 is also a strong support. Realistically a break of $20.97 is too much and ends the bullish setup.

The Moving Average Convergence Divergence (MACD) indicator has also been trending lower since December 2020. Look to this for a confirmation of the breakout setup. No technical indicator is perfect, but the more that align, the more risk is in your favour. Trading is not about being right all the time. It is about managing the probabilities and putting the risk-reward profile in your favour. That is how profit is consistently made.

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to PremiumSign In

Author

Ivan Brian

Ivan Brian

FXStreet

Ivan Brian started his career with AIB Bank in corporate finance and then worked for seven years at Baxter. He started as a macro analyst before becoming Head of Research and then CFO.

More from Ivan Brian
Share:

Editor's Picks

EUR/USD retakes 1.1800 on renewed USD weakness

EUR/USD gains ground after three days of losses, re-attempting 1.1800in the European trading hours on Thursday. The US Dollar sees fresh selling interest across the board, despite hawkish Fed Minutes, as the market mood improves and supports the pair. US Jobless Claims data, Fedspeak and geopolitics remain in focus. 

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold clings to gains above $5,000 amid safe-haven flows and Fed rate cut bets

Gold sticks to modest intraday gains, above the $5,000 psychological mark, through the first half of the European session, though it lacks bullish conviction amid mixed cues. The third round of US-mediated negotiations between Ukraine and Russia concluded in Geneva on Wednesday without any major breakthrough.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.